Univariate Analysis | Multivariate Analysis | ||||
---|---|---|---|---|---|
Variable* | No. of cases | HR(95%CI) | P† | HR(95%CI) | P† |
Age(≥62 y vs < 62 y) | 25/25 | 0.776(0.379,1.589) | 0.488 | ||
Sex(male vs female) | 36/14 | 0.803(0.475,1.359) | 0.414 | ||
Tumor diagnosis (Cholangiocarcinoma vs other neoplasms) | 25/25 | 0.825(0.439,1.552) | 0.552 | ||
Type of obstruction(proximal vs distal) | 19/31 | 0.932(0.490,1.775) | 0.825 | ||
Performance status score (2 vs ≤1) | 32/18 | 1.706(0.890,3.270) | 0.108 | ||
No. of interventions (1 vs ≥2) | 42/8 | 0.187(0.055,0.630) | 0.007 | 0.295(0.106,0.818) | 0.019 |
Previously cholangeitis (no vs yes) | 28/22 | 0.794(0.405,1.555) | 0.500 | ||
Distant Metastasis(yes vs no) | 29/21 | 0.897(0.474,1.698) | 0.739 | ||
Chemotherapy (no vs yes) | 43/7 | 0.273(0.094,0.792) | 0.017 | 2.0.465 (0.159,1.365) | 0.164 |
TB(≥168.0 μmol/L vs <168.0 μmol/L) | 25/25 | 1.038(0.544,1.978) | 0.911 | ||
DB(≥95.1 μmol/L vs < 95.1 μmol/L) | 25/25 | 0.901(0.475,1.706) | 0.748 | ||
ALT (≥71 U/L vs <71 U/L) | 25/25 | 1.495(0.791,2.825) | 0.216 | ||
AST (≥72.5 U/L vs < 72.5 U/L) | 25/25 | 1.087(0.575,2.056) | 0.798 | ||
GGT(≥311 U/L vs < 311 U/L) | 25/25 | 1.100(0.584,2.072) | 0.767 |